Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan
Rationale & Objective: The impact of tolvaptan on health-related quality-of-life (HRQoL) in patients with autosomal dominant polycystic kidney disease (ADPKD) is unknown. To address this knowledge gap, we studied patient-reported HRQoL in patients enrolled in the Bern ADPKD registry. Study Desig...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-03-01
|
| Series: | Kidney Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S259005952030025X |